Table 2 Synopsis of recent case reports decribing various phototherapeutic alternatives in a number of sclerotic rarities. [Categories: A – double-blind, randomized, placebo-controlled; B – open, randomised; C – open, non-randomized; D – case series; E – case report]

Eosinophilic fasciitis

UVA1⁸⁰

low-dose

E

benefit, no valid data available

PUVA⁸¹

medium-dose

E

Pansclerotic morphea

UVA⁸⁴

low-dose

E

possible efficacy as an adjunct therapy,

UVA1⁸³

low-dose

E

no valid data available

PUVA^85,86

medium-dose

E

Scleromyxedema

PUVA^90–92

high-dose

E

controversial, possible efficacy as an adjunct therapy, no valid data available

Scleredema adultorum Buschke

PUVA^95,96

high-dose

E, D

possible therapeutic alternative, cream therapy, no valid data available

POEMS

UVA1⁹⁸

low-dose

E

benefit, no valid data available

Bleomycin-induced scleroderma

UVA1⁹⁹

low-dose

E

limited success, no valid data available

Pansclerotic porphyria cutanea tarda

UVA1¹⁰¹

medium-dose

E

benefit, no valid data available